Seth Lederman just Paid for 500 shares of Tonix Pharmaceuticals Holding Corp. (TNXP), be careful if you are short!; BLACKPOLL FLEET INTERNATIONAL (BPOL) Shorts Down By 7.69%

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Logo

BLACKPOLL FLEET INTERNATIONAL INC (OTCMKTS:BPOL) had a decrease of 7.69% in short interest. BPOL’s SI was 1,200 shares in July as released by FINRA. Its down 7.69% from 1,300 shares previously. With 100 avg volume, 12 days are for BLACKPOLL FLEET INTERNATIONAL INC (OTCMKTS:BPOL)’s short sellers to cover BPOL’s short positions. It closed at $2 lastly. It is down 0.00% since July 1, 2017 and is . It has underperformed by 12.57% the S&P500.

The stock decreased 2.84% or $0.13 during the last trading session, reaching $4.45. About 182,126 shares traded or 52.95% up from the average. Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) has declined 28.97% since July 1, 2017 and is downtrending. It has underperformed by 41.54% the S&P500. Some Historical TNXP News: 03/04/2018 – Tonix Pharmaceuticals Achieves 50 Percent Enrollment in Phase 3 Trial of FDA-Designated Breakthrough Therapy Tonmya® (Cycloben; 04/04/2018 – Tonix Pharmaceuticals to Present FDA Breakthrough Therapy-Designated PTSD Program at the MicroCap Conference in New York; 14/05/2018 – TONIX SEES INTERIM PHASE 3 HONOR STUDY OF TONMYA FOR PTSD IN 3Q; 01/05/2018 – TONIX GETS IND CLEARANCE BY FDA FOR TNX-102 SL; 22/04/2018 – DJ Tonix Pharmaceuticals Holding Corp, Inst Holders, 1Q 2018 (TNXP); 03/04/2018 – TONIX PHARMACEUTICALS – EVIDENCE FROM PHASE 2 STUDY OF TONMYA SHOWED POTENTIAL IMPROVEMENT OVER EXISTING THERAPIES USED TO TREAT MILITARY-RELATED PTSD; 24/05/2018 – TONIX PHARMACEUTICALS HOLDING CORP – MAJORITY OF AES WERE MILD AND TRANSIENT, AND NONE LED TO PK STUDY DISCONTINUATION; 12/03/2018 Tonix Pharmaceuticals 4Q Loss/Shr 71c; 21/03/2018 – Tonix Pharmaceuticals Expands Intellectual Property Portfolio for TNX-102 SL; 01/05/2018 – Tonix Pharmaceuticals Receives IND Clearance by U.S. FDA for TNX-102 SL in Agitation in Alzheimer’s Disease

More notable recent Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) news were published by: Seekingalpha.com which released: “Premarket analyst action – healthcare” on June 06, 2018, also Streetinsider.com with their article: “B.Riley/FBR Starts Tonix Pharma (TNXP) at Buy” published on June 06, 2018, Benzinga.com published: “40 Biggest Movers From Friday” on June 18, 2018. More interesting news about Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) were released by: Benzinga.com and their article: “40 Biggest Movers From Yesterday” published on June 07, 2018 as well as Benzinga.com‘s news article titled: “24 Stocks Moving In Wednesday’s Pre-Market Session” with publication date: June 06, 2018.

Analysts await Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) to report earnings on August, 13. They expect $-0.73 EPS, down 12.31% or $0.08 from last year’s $-0.65 per share. After $-0.88 actual EPS reported by Tonix Pharmaceuticals Holding Corp. for the previous quarter, Wall Street now forecasts -17.05% EPS growth.

The Chief Executive Officer of Tonix Pharmaceuticals Holding Corp, Seth Lederman has made a sudden trade in the corporation that is having a worth of $2,290 USD. According to the U.S. SEC report filed on June 29, 2018, Seth purchased 500 shares calculated with average price per share of $4.6. This is not his first insider trade, in the last 30 days, he obtained another 7,500 shares worth $28,065 USD. Seth Lederman now holds 94,764 shares of the Firm.